Condition
Pheochromocytoma/Paraganglioma (PPGL) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Pheochromocytoma/Paraganglioma (PPGL) clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Al18F-NOTA-LM3 PET/CT imaging for pheochromocytoma and paraganglioma
This will test whether Al18F-NOTA-LM3 PET/CT finds pheochromocytoma and paraganglioma lesions as well as or better than 68Ga-DOTATATE PET/CT in adults with suspected or confirmed PPGL.
-
Using a new imaging agent to detect various cancers
This study is testing a new imaging agent to see if it can better detect certain cancers in adults compared to standard imaging methods.
Related topics
Quick answers
How many Pheochromocytoma/Paraganglioma (PPGL) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.